EMEA-000420-PIP01-10

Adopted

First published: 21/12/2010
Last updated: 22/06/2021
EMA/704354/2010

Invented name	Ariclaim Yentreve Nodetrip (previously Xeristar) Cymbalta Xeristar
Active substance	duloxetine hydrochloride
Therapeutic area	Uro-nephrology
Decision number	P/268/2010
PIP number	EMEA-000420-PIP01-10
Pharmaceutical form(s)	Capsule, hard Gastro-resistant capsule
Condition(s) / indication(s)	Treatment of chronic pain Treatment of diabetic neuropathic pain Treatment of generalised anxiety disorder Treatment of major depressive disorder Treatment of stress urinary incontinence
Route(s) of administration	Oral use
Contact for public enquiries	Eli Lilly & Company Limited E-mail: eu_paediatric@lilly.com Tel. +44 (0)1276 483000
Decision type	W: decision granting a waiver in all age groups for all conditions or indications